Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Azithromycin less costly than roxithromycin in pharyngitis

    • 5 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Azithromycin less costly than roxithromycin in pharyngitis. Pharmacoecon. Outcomes News 76, 5 (1996). https://doi.org/10.1007/BF03270207

    Download citation

    Keywords

    • Azithromycin
    • Societal Perspective
    • Pharyngitis
    • Roxithromycin
    • Antimicrobial Chemotherapy